Advertisement

Ethical and Regulatory Aspects of Personalized Medicine

Chapter

Abstract

Most of the ethical aspects of personalized medicine are based on pharmacogenetics, genetic screening and impact on healthcare. Understanding the social effects of genomics requires an analysis of the ways in which genetic information and a genetic approach to disease affect people individually, within their families and communities, and in their social and working lives. This information will lead to measures for the prevention of stigmatization and discrimination of different populations on ethnic grounds.

Keywords

Critical Path Personalized Medicine National Human Genome Research Institute Companion Diagnostics Pharmacogenomic Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Caulfield T, McGuire AL, Cho M et al (2008) Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol 6:e73.Google Scholar
  2. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Eng J Med 354:1264–1272CrossRefGoogle Scholar
  3. Geransar R, Einsiedel E (2008) Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genetic Testing 12:13–23CrossRefPubMedGoogle Scholar
  4. Hunter AM, Leuchter AF, Morgan ML et al (2005) Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology 30:792–799PubMedGoogle Scholar
  5. Jain KK (2009a) Molecular diagnostics: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.Google Scholar
  6. Lesko LJ, Woodcock J (2004) Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov 3:763–769Google Scholar
  7. Offit K (2008) Genomic profiles for disease risk: predictive or premature? JAMA 299:1353–1355CrossRefPubMedGoogle Scholar
  8. Prainsack B, Reardon J, Hindmarsh R et al (2008) Personal genomes: misdirected precaution. Nature 456:34–35CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Jain PharmaBiotechBaselSwitzerland

Personalised recommendations